Back
Day Range
$14.67
$16.18
52-Week Range
$8.18
$22.50
Volume
2,161,122
50D / 200D Avg
$16.70
/
$13.53
Prev Close
$14.44
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -5.1 | 0.3 |
| P/B | 2.5 | 3.0 |
| ROE % | -49.6 | 3.7 |
| Net Margin % | -314.9 | 3.8 |
| Rev Growth 5Y % | 29.6 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$31.22
+102.2%
Low: $28.00
High: $36.00
Forward EPS
-$3.13
Est. Revenue
57.53M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
-$0.35
-$0.65 – -$0.14
|
492.66M | 4 |
| FY2029 |
-$1.92
-$3.52 – -$0.76
|
241.67M | 4 |
| FY2028 |
-$2.51
-$3.48 – -$1.31
|
114.55M | 10 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-28 | -$0.84 | -$0.82 | +2.4% |
| 2025-10-09 | -$0.84 | -$1.03 | -22.6% |
| 2025-07-09 | -$0.71 | -$0.52 | +26.8% |
| 2025-04-08 | -$0.72 | -$0.67 | +6.9% |
| 2025-01-28 | -$0.67 | -$0.75 | -11.9% |
| 2024-10-11 | -$0.67 | -$0.67 | 0.0% |
| 2024-07-11 | -$0.66 | -$0.71 | -7.6% |
| 2024-04-10 | -$0.80 | -$0.76 | +5.0% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 29.62% annually over 5 years — strong growth
Debt/Equity of 0.10 — conservative balance sheet
Negative free cash flow of -263.47M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 24.33%
Growth
Revenue Growth (5Y)
29.62%
Revenue (1Y)53.95%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-49.63%
ROIC-36.04%
Net Margin-314.90%
Op. Margin-340.16%
Safety
Debt / Equity
0.10
Current Ratio7.02
Interest Coverage0.00
Valuation
P/E Ratio
-5.06
Forward P/EN/A
P/B Ratio2.48
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 53.95% | Revenue Growth (3Y) | 4.44% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 29.62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 83.98M | Net Income (TTM) | -264.46M |
| ROE | -49.63% | ROA | -38.43% |
| Gross Margin | 77.55% | Operating Margin | -340.16% |
| Net Margin | -314.90% | Free Cash Flow (TTM) | -263.47M |
| ROIC | -36.04% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.10 | Current Ratio | 7.02 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -5.06 | Forward P/E | N/A |
| P/B Ratio | 2.48 | P/S Ratio | 15.93 |
| PEG Ratio | -0.94 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 23.26 | Fwd Earnings Yield | N/A |
| FCF Yield | -19.69% | ||
| Market Cap | 1.34B | Enterprise Value | 1.15B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 83.98M | 54.55M | 76.99M | 38.63M | 29.75M |
| Net Income | -264.46M | -193.57M | -143.95M | -180.36M | -117.19M |
| EPS (Diluted) | -3.05 | -2.88 | -2.65 | -3.71 | -2.73 |
| Gross Profit | 65.12M | -167.08M | -112.16M | -145.87M | -86.68M |
| Operating Income | -285.67M | -213.03M | -155.06M | -183.87M | -117.89M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 688.14M | 669.34M | 355.60M | 416.76M | 476.77M |
| Total Liabilities | 149.39M | 142.35M | 155.11M | 113.06M | 134.47M |
| Shareholders' Equity | 538.75M | 526.99M | 200.49M | 303.70M | 342.30M |
| Total Debt | 55.73M | 28.30M | 30.61M | 11.96M | 13.04M |
| Cash & Equivalents | 246.96M | 110.00M | 54.63M | 64.47M | 80.51M |
| Current Assets | 606.82M | 619.39M | 295.50M | 318.45M | 311.12M |
| Current Liabilities | 86.47M | 95.85M | 86.96M | 70.66M | 66.26M |